Cited by 352Liver Disease Diagnosis and TreatmentProbiotics and Fermented FoodsGut microbiota and health

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis

Open access

Ma, Yan-Yan·2013·World Journal of Gastroenterology

DOI 10.3748/wjg.v19.i40.6911PMC PMC3812493

Open this paper in CoChat — free account Open PDF

Abstract

AIM: To investigate the relationship between the gut-liver axis and nonalcoholic fatty liver disease (NAFLD), we performed a meta-analysis to evaluate the effects of probiotic therapy in NAFLD. METHODS: We searched PubMed, Medline, Embase, Web of Science, the Cochrane Library and Chinese Biomedicine Database for all relevant randomized controlled trials on probiotics in patients with NAFLD/nonalcoholic steatohepatitis (NASH). A statistical analysis was performed using RevMan 5.0 software. RESULTS: Four randomized trials involving 134 NAFLD/NASH patients were included. The results showed that probiotic therapy signiﬁcantly decreased alanine aminotransferase (ALT), aspartate transaminase (AST), total-cholesterol (T-chol), high density lipoprotein (HDL), tumor necrosis factor (TNF)-α and homeostasis model assessment of insulin resistance (HOMA-IR) [ALT: weighted mean difference (WMD) -23.71, 95%CI: -33.46--13.95, P < 0.00001; AST: WMD -19.77, 95%CI: -32.55--7.00, P = 0.002; T-chol: WMD -0.28, 95%CI: -0.55--0.01, P = 0.04; HDL: WMD -0.09, 95%CI: -0.16-0.01, P = 0.03; TNF-α: WMD -0.32, 95%CI: -0.48--0.17, P < 0.0001; HOMA-IR: WMD -0.46, 95%CI: -0.73--0.19, P = 0.0008]. However, the use of probiotics was not associated with changes in body mass index (BMI), glucose (GLU) and low density lipoprotein (LDL) (BMI: WMD 0.05, 95%CI: -0.18-0.29, P = 0.64; GLU: WMD 0.05, 95%CI: -0.25-0.35, P = 0.76; LDL: WMD -0.38, 95%CI: -0.78-0.02, P = 0.06). CONCLUSION: Probiotic therapies can reduce liver aminotransferases, total-cholesterol, TNF-α and improve insulin resistance in NAFLD patients. Modulation of the gut microbiota represents a new treatment for NAFLD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3748/wjg.v19.i40.6911

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,480
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548

Show all 63 references

Research works printed but not linked: 2

Salminen S. Uniqueness of probiotic strains. IDF Nutr News- letter 1996; 5: 16-18 13
Hofacre CL, Mathis GF, Quiroz MA. Natural alternatives to prevent necrotic enteritis. Int Poult Prod 2005; 13: 7-9 60

Sorted by citations

Items 201–300 of 352

Role of probiotics/synbiotic supplementation in glycemic control: A critical umbrella review of meta-analyses of randomized controlled trials
Xu, D., Fu, L., Pan, D., Chu, Y., Feng, M., Lü, Y., Yang, C., Wang, Y., Xia, J., & Sun, G. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2117783 · Cited by 19
Current and Emerging Approaches for Hepatic Fibrosis Treatment
Li, J., & Tuo, B. (2021) · Gastroenterology Research and Practice · doi:10.1155/2021/6612892 · Cited by 19
Pharmacogenomic and Personalized Approaches to Tackle Nonalcoholic Fatty Liver Disease
Lorbek, G., Urlep, Ž., & Rozman, D. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0047 · Cited by 19
Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: A systematic review and network meta-analysis
Jin, H., Xu, X., Pang, B., Yang, R., Sun, H., Jiang, C., Shao, D., & Shi, J. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0183 · Cited by 18
The gut–pancreas axis: investigating the relationship between microbiota metabolites and pancreatic steatosis
Kırsoy, F., Yalnız, M., Bahçecioğlu, İ. H., Artaş, H., Türkoğlu, S., Solmaz, O., & Tawheed, A. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03685-6 · Cited by 18
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
Cernea, S., & Onișor, D. M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i2.286 · Cited by 18
Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota
El-Baz, A. M., El-Ganiny, A. M., Hellal, D., Anwer, H. M., El-Aziz, H. A. A., Tharwat, I. E., El-Adawy, M. A., Helal, S. E.-D. M., Mohamed, M. T. A., Azb, T. M., et al. (2023) · AMB Express · doi:10.1186/s13568-023-01561-8 · Cited by 17
Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials
Amini‐Salehi, E., Nayak, S. S., Maddineni, G., Mahapatro, A., Keivanlou, M., Moghadam, S. S., Vakilpour, A., Aleali, M. S., Joukar, F., Hashemi, M., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001740 · Cited by 17
Pediatric non-alcoholic fatty liver disease: Recent advances
Corte, C. D., Vajro, P., Socha, P., & Nobili, V. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.02.008 · Cited by 17
Probiotics for dietary management of non-alcoholic fatty liver disease
Elshaghabee, F. M. F., Rokana, N., Panwar, H., Heller, K. J., & Schrezenmeir, J. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-019-00896-8 · Cited by 17
Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model
Kim, H., Lee, K., Kim, J., Shim, J.-J., Lim, J., Kim, J.-Y., & Lee, J.-L. (2023) · Microorganisms · doi:10.3390/microorganisms11102466 · Cited by 16
Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences
Vitetta, L., Hall, S., & Coulson, S. (2015) · Microorganisms · doi:10.3390/microorganisms3040913 · Cited by 15
Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?
Hatton, G. B., Alterio, T., Nobili, V., & Mann, J. P. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1512853 · Cited by 15
Shaping the future of gastrointestinal cancers through metabolic interactions with host gut microbiota
Xie, W., Sharma, A., Kaushik, H. K., Sharma, L., Nistha, Anwer, M. K., Sachdeva, M., Elossaily, G. M., Zhang, Y., Pillappan, R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35336 · Cited by 14
Overview and recent trends of systematic reviews and meta-analyses in hepatology
Kim, G., & Baik, S. K. (2014) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2014.20.2.137 · Cited by 13
The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease
Kim, A., Krishnan, A., Hamilton, J. P., & Woreta, T. A. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.10.013 · Cited by 12
Modulatory Effect of Probiotics on Proinflammatory Cytokine Levels in Acrylamide-Treated Rats
Seifati, S. M., Zaker, E., Fesahat, F., Zare, F., & Hekmatimoghaddam, S. (2021) · Biochemistry Research International · doi:10.1155/2021/2268770 · Cited by 12
Probiotics and Liver Disease
Elzouki, A.-N. Y. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000712 · Cited by 12
Gut-skin axis: Emerging insights for gastroenterologists-a narrative review
Singla, N., Singla, K., Attauabi, M., & Aggarwal, D. (2025) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v16.i3.108952 · Cited by 11
Interaction between mucus layer and gut microbiota in non-alcoholic fatty liver disease: Soil and seeds
Zhang, B., Li, J., Fu, J., Shao, L., Yang, L., & Shi, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002711 · Cited by 11
The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
Yaghmaei, H., Bahanesteh, A., Soltanipur, M., Takaloo, S., Rezaei, M., & Siadat, S. D. (2024) · International Journal of Hepatology · doi:10.1155/2024/4183880 · Cited by 11
Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation
Айтбаев, К. А., Murkamilov, I. T., & Fomin, V. V. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh2017898120-128 · Cited by 11
Harnessing lactobacillus : a probiotic revolution in combating metabolic dysfunction-associated steatotic liver disease
Gu, M., Hong, Q., Cui, J., Li, W., Zhang, J., Sun, Y., Jiang, J., & Hu, Y. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2504162 · Cited by 10
Probiotics for the Treatment of Liver Disease
Punzalan, C., & Qamar, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00040-9 · Cited by 10
Youngia denticulata attenuates diet-induced obesity-related metabolic dysfunctions by activating AMP-activated protein kinase and regulating lipid metabolism
Kim, M., Park, Y. G., Lee, H.-J., Lim, S. J., Ahn, H. R., Jung, S. H., & Nho, C. W. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.09.002 · Cited by 10
A bél–máj tengely vizsgálata colitis ulcerosában. Retrospektív tanulmány
Egresi, A., Kovács, Á., Szilvás, Á., & Blázovics, A. (2017) · Orvosi Hetilap · doi:10.1556/650.2017.30781 · Cited by 10
Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease
Bakhshimoghaddam, F., & Alizadeh, M. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.10.01 · Cited by 10
Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease
Zhang, Y., Wang, T., Han, J., Song, J., Yang, C., Liang, L., Li, H., & Wang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610498 · Cited by 9
Effects of Fish Oil Supplementation on Reducing the Effects of Paternal Obesity and Preventing Fatty Liver in Offspring
Shrestha, A., Dellett, S. K., Yang, J., Sharma, U., & Ramalingam, L. (2023) · Nutrients · doi:10.3390/nu15245038 · Cited by 9
Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review
Avelar-Rodríguez, D., Peña-Vélez, R., Popov, J., Hill, L., & Ryan, P. M. (2022) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2022.8796/2022 · Cited by 8
Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health
Kandalgaonkar, M. R., Kumar, V., & Vijay–Kumar, M. (2024) · Physiological Reports · doi:10.14814/phy2.16114 · Cited by 8
Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
Xia, Q., Lei, Y., Wang, J., & Wang, Q. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0741 · Cited by 8
Role of the portal system in liver regeneration: From molecular mechanisms to clinical management
Xu, H., Qiu, X., Wang, Z., Wang, K., Tan, Y., Gao, F., Perini, M. V., & Xu, X. (2024) · Liver Research · doi:10.1016/j.livres.2024.01.002 · Cited by 8
More evidence that probiotics may have a role in treating fatty liver disease
Maddur, H., & Neuschwander‐Tetri, B. A. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.082636 · Cited by 8
The gut microbiome and nonalcoholic fatty liver disease
Nadeau, B. A., & Conjeevaram, H. S. (2017) · Clinical Liver Disease · doi:10.1002/cld.671 · Cited by 7
PROBIOTIC, PREBIOTIC OR SYMBIOTIC SUPPLEMENTATION IMPACTS ON INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW
de Souza, C. A., Rocha, R., Costa, P. R. D. F., Almeida, N. S., & Cotrim, H. P. (2022) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202200001-21 · Cited by 7
The day will come to treat HCC in a drugstore?
Miura, K. (2017) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.07.09 · Cited by 7
Effect of fish paste products, fish balls ‘tsumire’, intake in Sprague–Dawley rats
Kadokura, K., Tomita, T., & Suruga, K. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.57 · Cited by 6
Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
Maslennikov, R. V., & Evsyutina, Y. V. (2018) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2018-28-4-84-90 · Cited by 6
Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis
Hatton, G. B., Ran, S., Tranah, T. H., & Shawcross, D. L. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00520-2 · Cited by 6
THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW
Chaves, F. G. B., de Oliveira, G. F., Ribeiro, J. P. A., Serafim, J. V., Cordeiro, L. F. M., Alvares, M. A., Cecchi, M. T., Vasquez, M. C., de Souza, T. B. D., & Rullo, V. E. V. (2020) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/2021/39/2019226 · Cited by 6
The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)—A Systematic Review and Meta-Analysis
Rosqvist, F., Rydell, A., & Iggman, D. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.613221 · Cited by 6
Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes
Mastromauro, C., Polidori, N., & Giannini, C. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001138 · Cited by 6
Probiotics—A Promising Novel Therapeutic Approach in the Management of Chronic Liver Diseases
Ramachandran, G., & Pottakkat, B. (2024) · Journal of Medicinal Food · doi:10.1089/jmf.2023.k.0129 · Cited by 5
Effect of the total flavonoids of Dracocephalum moldavica L. on metabolic associated fatty liver disease in rats
Sun, X., Ge, N., Liang, Q., Wang, Q., Yu, H., & Jin, M. K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1549515 · Cited by 5
Mechanistic roles and intervention strategies involving gut microbiota, amino acid metabolism, and the tumor immune microenvironment in MAFLD-HCC progression
Guo, Z., Yao, Z., Chen, X., Wu, D., Ouyang, Y., Shen, Y., Wang, Y., Zhang, H., Lu, Y., & Lv, W. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01906-6 · Cited by 5
Nonalcoholic Fatty Liver Disease and the Gut Microbiota: Exploring the Connection
Oldfield, E. C., & Dong, R. (2014) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000245 · Cited by 5
Microbiome and Obesity
Falalyeyeva, T. M., Kobyliak, N. M., Korotkyi, O., Meleshko, T., Sulaieva, O., Hryshchenko, I., Domylivska, L., & Boyko, N. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_5 · Cited by 5
EFFECT OF GREEN TEA ON HEPATIC CELLS UNDER THE INFLUENCE OF INFLAMMATORY CONDITIONS: IN VITRO STUDY
Saleh, I. G. (2013) · American Journal of Pharmacology and Toxicology · doi:10.3844/ajptsp.2013.209.217 · Cited by 5
The Gut Microbiota and the Hepatologist: Will Our Bugs Prove to be the Missing Link?
Pallen, M. J., & Quraishi, M. N. (2017) · Digestive Diseases · doi:10.1159/000456590 · Cited by 5
What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?
Mansour, A., Hekmatdoost, A., & Mirmiran, P. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12751 · Cited by 5
Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen
Wree, A., Geisler, L. J., & Tacke, F. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0755-2595 · Cited by 5
Microbial Community of Kefir and its Impact on the Gastrointestinal Microbiome in Health and Disease
Lazda, I., Krūmiņa, A., Zeltiņa, I., Krūmiņa, N., Ķibilds, J., Siksna, I., Vīksna, L., & Derovs, A. (2020) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2020-0009 · Cited by 5
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment
Maddineni, G., Obulareddy, S. J., Paladiya, R. D., Korsapati, R. R., Jain, S., Jeanty, H., Vikash, F., Tummala, N., Shetty, S., Ghazalgoo, A., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002276 · Cited by 4
Possible hepatocellular toxicity of EGCG under the influence of an inflammagen
Saleh, I. G., Ali, Z., Abe, N., Hamada, F. M. A., Abd‐Ellah, M. F., Walker, L., Khan, I. A., & Ashfaq, M. K. (2014) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2014.03.001 · Cited by 4
Non-alcoholic Fatty Liver Disease and the Gut Microbiota: Exploring the Connection
Oldfield, E. C., Dong, R., & Johnson, D. A. (2015) · Gastro - Open Journal · doi:10.17140/goj-1-107 · Cited by 4
An umbrella review of meta-analyses on the effects of microbial therapy in metabolic dysfunction-associated steatotic liver disease
Yao, Y., Hong, Q., Ding, S., Cui, J., Li, W., Zhang, J., Sun, Y., Yu, Y., Yu, M., Zhang, C., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.02.007 · Cited by 4
Lactobacillus-based probiotics restore gut microbial balance in weaned rabbits: Insights into dietary modulation and molecular docking analysis
Ghany, K. A. E., Mallasiy, L. O., Haredy, S. A., Ahmed-Farid, O. A.-H., Aboukhezam, B., & Elshafey, N. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106466 · Cited by 4
Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver disease
dos Santos, A. C., Ribeiro, D. A., Ferreira, J. A. D. C., Aguiar, O., Waitzberg, D. L., & Alves, C. C. (2018) · Nutrition & Food Science · doi:10.1108/nfs-04-2018-0119 · Cited by 4
Dietary Approach to NAFLD
Sanchez-Torrijos, Y. M., Álvarez‐Amor, L., Aller, R., García‐Luna, P. P., Martín, F., & Romero‐Gómez, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_15 · Cited by 4
Microbiota, Liver Diseases, and Alcohol
Cassard, A., Gérard, P., & Perlemuter, G. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch8 · Cited by 4
Role of the gut microbiome and probiotics for prevention and management of tuberculosis
Baral, T., Kurian, S. J., Miraj, S. S., Munisamy, M., Kudru, C. U., Khandelwal, B., Banerjee, M., Mukhopadhyay, C., Saravu, K., Singh, J., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00036-4 · Cited by 4
Future Impact of Probiotic Therapy of Metabolic Disorder
El‐Sayyad, H. I. (2017) · Cited by 4
Sweetening Sixteen
Phatak, S., Saboo, B., Dwivedi, S., Zinzuwadia, P., Panchal, D., Ganguli, A., & Hasnani, D. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_9_20 · Cited by 4
Non-pharmacological treatment approach in patients with metabolic dysfunction-associated liver disease
Lara, C., López-Bermudo, L., Gómez, M. F., Cornejo, A., Berná, G., & Romero‐Gómez, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00019-7 · Cited by 3
Exploring the Role of Probiotics, Prebiotics, and Synbiotics in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease—A Scoping Review
Ntikoudi, A., Papachristou, A., Spirou, A., Evangelou, E., Tsartsalis, A. N., Vlachou, E. D., & Mastorakos, G. P. (2025) · Livers · doi:10.3390/livers5030031 · Cited by 3
Effect of probiotic and metformin combination therapy on insulin resistance in polycystic ovary syndrome compared with metformin alone
Jahan, S. T., Shamsi, A. M. O. I., Laila, R., Aziz, I., Sultana, R., Tarique, M. M. A., & Banu, J. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20252716 · Cited by 3
Probiotic-Derived Strain-Specific Metabolites Ameliorate Metabolic Dysfunction–Associated Steatotic Liver Disease through Modulation of the Gut-Liver Axis
Yoon, S. J., Choi, J., Won, S., Yu, J. S., Kim, H. Y., Joung, H., Park, I. G., Eom, J. A., Han, S. H., Lee, D. Y., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10761-6 · Cited by 3
Probiotics to Treat Visceral Obesity and Related Liver Disease
Vajro, P., Poeta, M., Pierri, L., Pizza, C., D’Aniello, R., Sangermano, M., Massa, G., & Paolella, G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407869-7.00033-7 · Cited by 3
High-intensity interval training with probiotic supplementation decreases gene expression of NF-κβ and CXCL2 in small intestine of rats with steatosis
Mohammadi, S., Rostamkhani, F., Malayeri, S. R., & Shirvani, H. (2021) · Sport Sciences for Health · doi:10.1007/s11332-021-00829-5 · Cited by 3
Stem cell intervention ameliorates epigallocatechin-3-gallate/lipopolysaccharide-induced hepatotoxicity in mice
Saleh, I. G., Ali, Z., Hammad, M., Wilson, F., Hamada, F. M., Abd‐Ellah, M. F., Walker, L., Khan, I., & Ashfaq, M. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115572707 · Cited by 3
Az idült májbetegségek progressziójához vezető folyamatok
Egresi, A., Lengyel, G., Somogyi, A., Blázovics, A., & Hagymási, K. (2016) · Orvosi Hetilap · doi:10.1556/650.2015.30377 · Cited by 3
FMT in Clostridium difficile and Other Potential Uses
Fine, S., & Kelly, C. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00034-3 · Cited by 3
Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
Alabagi, A., Reynolds, C. A., & A‐Kader, H. H. (2016) · European Medical Journal · doi:10.33590/emj/10314771 · Cited by 3
Health Effects of Probiotics on Nonalcoholic Fatty Liver in the Life Cycle Based on Data Analysis
Wang, J., Hao, Y., Jin, X., Li, X., Liu, Y., Zhang, L. R., Wang, J., & Hu, M. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/2123162 · Cited by 2
Treating the patient with nonalcoholic fatty liver disease
Chaney, A. J. (2015) · The Nurse Practitioner · doi:10.1097/01.npr.0000472248.28703.18 · Cited by 2
Lactobacillus helveticus HY7804 Modulates the Gut–Liver Axis to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease in a Mouse Model
Kim, H., Jeon, H.-J., Jeong, J.-W., Lee, K., Gwon, H., Lee, D., Kim, J.-Y., Shim, J.-J., & Lee, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083557 · Cited by 2
Efficacy of interventions with live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials
Wu, Y., Wu, H., & Yi, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610426 · Cited by 2
Non-alcoholic Fatty Liver Disease in Obesity
Ferolla, S. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19821-7_13 · Cited by 2
Pharmacologic Management of Non-Alcoholic Fatty Liver Disease
Goh, G. B. (2014) · Advances in Pharmacoepidemiology & Drug Safety · doi:10.4172/2167-1052.1000157 · Cited by 2
The Relationship Between the Gut Microbiota and Liver Disease.
Bajaj, J. S. (2015) · PubMed Central · Cited by 2
Pharmacological Approaches for Nonalcoholic Fatty Liver Disease
Ionică, F. E., Negreș, S., Bejenaru, L. E., Bejenaru, C., & Chiriţă, C. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0037 · Cited by 2
LC-QToF-Based Metabolomics Identifies Aberrant Tissue Metabolites Associated with a Higher-Fat Diet and Their ‘Reversion to Healthy’ with Dietary Probiotic Supplementation
Dailey, A., Solano-Aguilar, G. I., Urban, J. F., & Couch, R. D. (2023) · Metabolites · doi:10.3390/metabo13030358 · Cited by 2
Gut microbiota and nonalcoholic fatty liver disease
Kim, B., & Kim, B. K. (2023) · Kosin Medical Journal · doi:10.7180/kmj.23.138 · Cited by 2
Comparative study on the effect of Probiotics and Silymarin on renal cortex in a rat model of high-fat, high-fructose diet
Samir, N., Fawzy, H. M., & Tarek, M. (2023) · Ain Shams Medical Journal · doi:10.21608/asmj.2023.235661.1168 · Cited by 2
Editorial: probiotics in NASH – more studies are needed
Ong, J. P., & Younossi, Z. M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12812 · Cited by 2
The Effect of Probiotic Supplementation as Alternative Therapy for NAFLD: A Literature Review
Adnan, M. L. (2021) · European Journal of Translational and Clinical Medicine · doi:10.31373/ejtcm/136328 · Cited by 1
Ameliorating effects of Lactobacillus probiotics on cadmium-induced hepatotoxicity, inflammation, and oxidative stress in Wistar rats
kohan, A., & Keshtmand, Z. (2024) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03583-5 · Cited by 1
Potential Beneficial Effects of Crab-Flavored Seafood Intake in Young Rats
Kadokura, K., Tomita, T., & Suruga, K. (2024) · Nutrition and Metabolic Insights · doi:10.1177/11786388241263717 · Cited by 1
Elucidating the effects of probiotics on metabolic dysfunction-associated steatotic liver disease: a meta-analysis
Vinner, G. K., Kreidler, L.-M., & Mak, L. L. Y. (2025) · Journal of Precision Health · doi:10.1186/s44450-025-00002-y · Cited by 1
Bacteroides thetaiotaomicron and Bacteroides ovatus for the treatment of MAFLD: A comparative study of individual and combined effects
Li, X., Zhou, G., Sun, C., She, R., Feng, W., Fu, X., Wu, S., Li, D., Pan, L., Liu, X., et al. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110377 · Cited by 1
Lipid-derived microbial metabolites at the gut-liver interface: regulation of intestinal barrier function, immune signaling, and metabolic inflammation
Acierno, C., Caturano, A., Barletta, F., Rinaldi, L., Sasso, F. C., Adinolfi, L. E., & Nevola, R. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1881697 · Cited by 1
Influence of Gut Microbiota on Hepatic Lipogenesis and Disease Pathogenesis
Singh, V., Yeoh, B. S., Ntambi, J. M., & Vijay–Kumar, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-25065-6_9 · Cited by 1
Living Medicines for Health and Disease Management
Jangra, S., & Pothuraju, R. (2020) · Springer eBooks · doi:10.1007/978-981-15-4099-8_18 · Cited by 1
The Effects of High-intensity Interval Training and Probiotic Consumption on Interleukin-10 and Interferon-gamma Gene Expression of Gut Tissue in an Animal Model of Fatty Liver
Rasheh, S., & Ahmadi, M. (2021) · Quarterly of Horizon of Medical Sciences · doi:10.32598/hms.27.3.3067.2 · Cited by 1
Effects of treatment of NAFLD on the metabolic syndrome
Yki‐Järvinen, H. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch21 · Cited by 1
Chapter 20: Prebiotics and Probiotics
Kale-Pradhan, P. B., & Wilhelm, S. M. (2017) · The American Pharmacists Association eBooks · doi:10.21019/9781582122656.ch20 · Cited by 1
Protective Effect of Maternal Prebiotics Against Neonatal Jaundice Induced by Phenylhydrazine in Rats
Liu, J., & Zhen, S. (2019) · International Journal of Pharmacology · doi:10.3923/ijp.2019.891.899 · Cited by 1
Treatment of Nonalcoholic Fatty Liver Disease through Changes in Gut Microbiome and Intestinal Epithelial Barrier
Heshmati, H. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97568 · Cited by 1
The Science Underlying the Probiotic Strain Bifidobacterium in Beneficial Effects on Immunological and Gastrointestinal Health
Ali, A., Islam, N., Fakir, N. I., Kabir, A., Sharmin, M., Islam, T., Rahman, M., Badal, F. A., & Taher, A. (2024) · International Journal of Immunology · doi:10.11648/j.iji.20241201.12 · Cited by 1

Authors: Ma, Y.-Y.
Venue: World Journal of Gastroenterology
Publisher: Baishideng Publishing Group Inc.
Published: 2013
Volume: 19
Issue: 40
Pages: 6911
ISSN: 1007-9327 (ISSN-L)
DOI: 10.3748/wjg.v19.i40.6911
PMC: PMC3812493
OpenAlex: W2151623669
Cited by: 352
References: 63
Citations by year: 2026: 7 · 2025: 21 · 2024: 23 · 2023: 23 · 2022: 26 · 2021: 39 · 2020: 19 · 2019: 35 · 2018: 24 · 2017: 42 · 2016: 24 · 2015: 42 · 2014: 26 · 2013: 1
FWCI: 3.67
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: World Journal of Gastroenterology (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: probiotics, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut-liver axis, alanine aminotransferase, aspartate aminotransferase, insulin resistance, TNF-α, serum cholesterol, HDL cholesterol, LDL cholesterol, body mass index, glucose, liver enzymes, dyslipidemia, inflammation
MeSH terms: Fatty Liver, Humans, Insulin Resistance, Intestines, Liver, Chi-Square Distribution, Odds Ratio, Treatment Outcome, Probiotics, Lipid Metabolism, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks